HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM
Number of holders
414
Total Shares
129M
Shares change
-2.22M
Total reported value, excl. options
$7.31B
Value change
-$116M
Put/Call ratio
0.31
Number of buys
187
Number of sells
-192
Price
$56.90
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.